Navigation Links
ShangPharma Announces Second Quarter 2011 Results
Date:8/22/2011

econd quarter of 2010, primarily due to higher non-GAAP profit from operations, which was partially offset by lower other income.  

Diluted earnings per ADS were $0.18, which compares with $0.26 in the second quarter of 2010.  

Non-GAAP diluted earnings per ADS were $0.25, which compares with $0.28 in the second quarter of 2010.

Financial Position  As of June 30, 2011, the Company had cash and cash equivalents of $41.6 million and short term debt of $0.8 million. During the quarter, capital expenditures totaled $11.0 million, including $5.5 million related to the purchase of a 68,000 square foot new lab and office building which replaced the original 36,000 square foot facility in Chengdu. The purchased lab and office building allows us to reduce overall expenditures and improve our earnings over time.  With a strong balance sheet and sound financial position, the Company is well positioned to make targeted investments when opportunities arise.  

Full Year 2011 GuidanceThe Company reconfirms its guidance for full year 2011.  The Company expects:

  • Net revenues to be approximately $111.1 – $115.6 million, which represents growth of approximately 23.0% – 28.0% compared with full year 2010.  
  • Non-GAAP gross margin to be approximately 33.5% – 35.5%, which is within the same range as non-GAAP gross margin of 34.5% in 2010.
  • Capital expenditure to be $28 - $32 million, including $6 million rolling payment lag impact carried forward from 2010.

  • This reflects the Company's current view and is subject to change.

    Conference CallShangPharma will host a conference call and live webcast at 8am New York time on August 22, 2011 (8pm Beijing time on August 22, 2011).  A PowerPoint presentation accompanying the prepared remarks will be available on the Company's website shortly before the call.  

    The dial-in details
    '/>"/>

    SOURCE ShangPharma Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

    Related biology technology :

    1. ShangPharma Corporation Named a Top Ten Chinese Outsourcing Enterprise
    2. ShangPharma Announces First Quarter 2011 Results
    3. ShangPharma Corp. to Announce Fourth Quarter and Full Year 2010 Financial Results on March 15, 2011
    4. Stem Cell Assurance, Inc. Announces Change of Name to BioRestorative Therapies, Inc.
    5. Syndax Pharmaceuticals Announces Issuance of EU Patent for Entinostat
    6. Regeneron Announces Review of Biologics License Application for EYLEA™ (aflibercept injection) Extended by Three Months by FDA
    7. ACMG Announces New Online Live Learning Center: Will Bring Genetics and Genomics Education to Varied Health Professionals
    8. Neurologix Announces Second Quarter 2011 Financial Results
    9. Bion Announces New U.S. Patent for Phosphorus Removal
    10. ViaCyte Announces Executive Management Changes
    11. NeoStem Announces the Receipt of Over $1,700,000 in DOD Funding for its VSEL™ Technology Being Developed to Treat Osteoporosis
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/2/2014)... Ore. -- Scientists, including University of Oregon chemist ... create scaffolds of self-assembling, synthetic proteins called peptoid ... , The accomplishment -- detailed this week in ... the Proceedings of the National Academy of ... alternative design of the two-dimensional peptoid nanosheets that ...
    (Date:9/2/2014)... NEW YORK , September 2, 2014 ... Market Study on Membrane Technology in Pharmaceutical, Biopharma and ... Witness Highest Growth by 2019" the global membrane technology market for ... 7,029.9 million in 2014 and is expected to grow ... to reach an estimated value of USD 10,886.0 million ...
    (Date:9/2/2014)... , Sept. 2, 2014  Technology Applications International ... that its wholly-owned subsidiary Renuell Int,l, Inc. has signed ... and Space Administration ("NASA") at the Johnson Space Center ... See photos: tapplic.com/houstonphotos/ ... are very pleased to announce our latest, exclusive agreement ...
    (Date:9/2/2014)... (PRWEB) September 02, 2014 Opertech ... new highly efficient, cost effective approach to sensory ... No. 8,820,265 by the U.S. Patent and Trademark ... Opertech. , “Opertech’s taste evaluation technology ... first automated high throughput system for rapid characterization ...
    Breaking Biology Technology:UO-Berkeley Lab unveil new nano-sized synthetic scaffolding technique 2Global Membrane Technology Market Will Reach $10,886.0 Million in 2019: Persistence Market Research 2Global Membrane Technology Market Will Reach $10,886.0 Million in 2019: Persistence Market Research 3Global Membrane Technology Market Will Reach $10,886.0 Million in 2019: Persistence Market Research 4Global Membrane Technology Market Will Reach $10,886.0 Million in 2019: Persistence Market Research 5Technology Applications International Corporation Subsidiary Enters Into Additional Exclusive Agreement with NASA at a Signing Ceremony at the Johnson Space Center In Houston, Texas 2Technology Applications International Corporation Subsidiary Enters Into Additional Exclusive Agreement with NASA at a Signing Ceremony at the Johnson Space Center In Houston, Texas 3Opertech Bio Receives U.S. Patent for High-Throughput Taste Evaluation Technology 2
    ... Therapeutics,Inc. (OTC Bulletin Board: ARNI), today announced that ... has changed from "LRRI.OB" to "ARNI.OB",effective July 17, ... Inc. is a clinical-stage biopharmaceutical company,that develops and ... Arno,s lead compound is AR-67, a novel, third-generation,camptothecin ...
    ... Supply Solutions(R),a focus area within SAFC(R), a ... today that the Company has launched a ... with their regulatory,requirement under the new European ... Authorization and restriction of Chemicals,(REACH) http://www.safcsupplysolutions.com/reach ...
    ... N.J., July 16 Johnson & Johnson Pharmaceutical,Research ... Food and Drug,Administration,s (FDA) Anti-Infective Drugs Advisory Committee ... for DORIBAX(TM) (doripenem for,injection) for the treatment of ... (VAP)., The committee voted that 500 mg ...
    Cached Biology Technology:Arno Therapeutics Announces New Ticker Symbol 2SAFC Supply Solutions Launches REACH-Compliant Products and Support 2SAFC Supply Solutions Launches REACH-Compliant Products and Support 3FDA Advisory Committee Provides Opinion of DORIBAX(TM) for the Treatment of Hospital-Acquired Pneumonia 2FDA Advisory Committee Provides Opinion of DORIBAX(TM) for the Treatment of Hospital-Acquired Pneumonia 3FDA Advisory Committee Provides Opinion of DORIBAX(TM) for the Treatment of Hospital-Acquired Pneumonia 4
    (Date:9/2/2014)... led by researchers at the University of Warwick in ... just published in the Journal Early Human Development ... spent in hospital after birth and the use of ... in preterm children. , Mathematic abilities are crucial for ... in very preterm children. Earlier studies of children who ...
    (Date:9/2/2014)... the battle between our immune systems and cholera bacteria, ... known as phages. In a new study, researchers from ... National Public Health Laboratory, and elsewhere, report that phages ... in order to survive. Importantly, the study published ... escape from phage predation occurs during human infection. , ...
    (Date:9/2/2014)... author Sam Kean stops by Reactions this week to ... shark that, despite what "Shark Week" may lead you ... at http://youtu.be/KhFygIoW_MA . , Kean,s book, "The Disappearing ... the History of the World from the Periodic Table ... a 10-episode video series produced for the newly launched ...
    Breaking Biology News(10 mins):Mechanical ventilation a key indicator for pre-term children's math problems 2War between bacteria and phages benefits humans 2War between bacteria and phages benefits humans 3
    ... New research from The University of Western Ontario leads ... the Arctic Circle during the Pleistocene Epoch (approx. 150,000 ... three years later than modern day African elephants due ... nursing pattern could have contributed to the prehistoric elephant,s ...
    ... 21, 2010 Reportlinker.com announces that a new market ... Indian Biometric Market http://www.reportlinker.com/p0351944/Indian-Biometric-Market.html ... fastest emerging technology in the Indian Securities & Identification ... many conventional methods of Identity & Security checks like, ...
    ... Miscanthus x giganteus is the forerunner in the ... researchers believe "putting all their eggs in one basket" could ... recently reported the first natural occurrence in several decades of ... M. x giganteus is the only variety available, ...
    Cached Biology News:Being good moms couldn't save the woolly mammoth 2New Miscanthus hybrid discovery in Japan could open doors for biofuel industry 2New Miscanthus hybrid discovery in Japan could open doors for biofuel industry 3
    Anti-hamster Ig HRP detection kit...
    The 50 ml Magnetic Separation Rack is designed to be used for small-scale separations using magnetic particles. ,Capacity: four 50 ml tubes. ,Magnets: Neodymium rare earth permanent magnets....
    ...
    Highly efficient electroporation solution suitable for transfection of plasmid DNA, oligonucleotides and siRNA. Compatible with all common electroporators....
    Biology Products: